Connect with us

Hi, what are you looking for?

News

FDA Authorizes Bivalent Covid Boosters for Children Under Age 5

On Thursday, the U.S. Food and Drug Administration announced that it expanded emergency use authorization for the bivalent COVID-19 booster for children between the ages of six months to 5 years old.

Now, children who have received the primary two-dose COVID-19 vaccine from Pfizer or Moderna could be eligible for the third shot (via CNBC):

The eligibility rules vary depending on whether children received Moderna’s or Pfizer’s original vaccines as their primary series.

Here are the eligibility criteria:

  • Children 6 months through 5 years old who received Moderna’s two-dose primary series are now eligible for an omicron booster two months after their second shot.
  • Kids ages 6 months through 4 years old who have not yet received the third dose of Pfizer’s primary series will now receive the omicron shot as their third dose.
  • But kids in the same age group who have already completed Pfizer’s three-dose primary series cannot get the omicron shot as a booster, or fourth dose, at this time.

The FDA did not specify in the announcement if children who’ve already received three doses of the vaccine are eligible for the bivalent shot targeted at Omicron.

FDA Commissioner Dr. Robert Califf said in a statement that people should continue getting booster shots as they become available because the vaccine wanes over time.

“As this virus has changed, and immunity from previous COVID-19 vaccination wanes, the more people who keep up to date on COVID-19 vaccinations, the more benefit there will be for individuals, families and public health by helping prevent severe illnesses, hospitalizations, and deaths,” Califf said.

Earlier this week, Townhall reported how Pharmaceutical corporation Pfizer and its German partner BioNTech submitted an application to FDA for Emergency Use Authorization of its COVID-19 omicron vaccine for children under 5.

“With the high level of respiratory illnesses currently circulating among children under 5 years of age, updated COVID-19 vaccines may help prevent severe illness and hospitalization,” the companies said in the press release.

Earlier this year, Townhall covered how the FDA delayed its review of the COVID-19 vaccine for children in this age demographic. Reportedly, the delay was, in part, because the initial two-dose vaccine regimen was not working well to protect against the Omicron variant.

READ 20 COMMENTS
  • ProudDeplorable says:

    Not in my household!!

  • Nunya says:

    All these pharmaceutical people and fed need to fucking hang and burn!

  • Jack Schitt says:

    Dems have been heard to say, “This holocaust isn’t just for adults, there a billions of children we must kill, also”!!!! Could be an exact quote from the pelosi factor!! WOKE YET????

  • Karen says:

    This is totally insane, these children at that age group don’t even get sick, and if they do they get over it. Let these children get immunity from diseases. Don’t get Covid shots for any age children.

  • TOP STORIES

    News

    Fulton County District Attorney Fani Willis has been hit with a lawsuit by an Atlanta lawmaker regarding her handling of an alleged stalking complaint....

    News

    As the political season heats up, former President Donald Trump’s search for a vice presidential candidate is beginning to garner more attention. With the...

    News

    A lawyer who was involved in the negotiations for agreements between former President Donald Trump and two women pushed back on prosecutors’ claims that...

    News

    The House of Representatives passed the “Antisemitism Awareness Act” (H.R. 6090) on Wednesday, which has sparked significant debate over the interpretation of religious texts...

    >